Personalized ESA doses for anemia management in hemodialysis patients with end‐stage renal disease
Authors:
- 1 January 2018
- journal article
- research article
- Published by Wiley in System Dynamics Review
- Vol. 34 (1-2) , 121-153
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Order Stability in Supply Chains: Coordination Risk and the Role of Coordination StockProduction and Operations Management, 2014
- Biomedical System Dynamics to Improve Anemia Control With Darbepoetin Alfa in Long-Term Hemodialysis PatientsMayo Clinic Proceedings, 2014
- A Dynamic Simulator for the Management of Disorders of the Body Water HomeostasisOperations Research, 2008
- Hemoglobin Variability and Mortality in ESRDJournal of the American Society of Nephrology, 2007
- Cellular Trafficking and Degradation of Erythropoietin and Novel Erythropoiesis Stimulating Protein (NESP)Journal of Biological Chemistry, 2006
- Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietinKidney International, 2005
- A generalized stock control formulation for stock management problems involving composite delays and secondary stocksSystem Dynamics Review, 2005
- Effects of Feedback Complexity on Dynamic Decision MakingOrganizational Behavior and Human Decision Processes, 1995
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Fluid therapy in acute large area burns: A system dynamics modelSystem Dynamics Review, 1985